Markets:

Overview

News

Currencies

International

Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

0.9042 -0.0158 (-1.72%)

Streaming Delayed Price Updated: 2:17 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InflaRx N.V. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 05, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite...

Via Benzinga

Inflarx NV (NASDAQ: IFRX) is One of Wednesday Morning’s Most Active Stocks

April 05, 2023

Via Investor Brand Network

Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher ↗

April 05, 2023

U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite dropping around 150 points on Wednesday. The Dow traded up 0.07% to 33,425.80 while the NASDAQ fell 1.27% to 11,972.78....

Via Benzinga

Why Shares of InflaRx Are Soaring Wednesday ↗

April 05, 2023

A key EUA from the FDA for the company's COVID-19 therapy gave the stock a jolt.

Via The Motley Fool

InflaRx Scores FDA Emergency Use Nod For COVID Antibody ↗

April 05, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About InflaRx ↗

August 08, 2022

InflaRx (NASDAQ:IFRX) has observed the following analyst ratings within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023 ↗

April 05, 2023

Via Benzinga

Why Is Liminal Biosciences (LMNL) Stock Up 77% Today? ↗

April 05, 2023

Liminal Biosciences (LMNL) stock is taking off on Wednesday as investors react to the company getting an unsolicited transaction proposal.

Via InvestorPlace

FDX Stock: What to Know as FedEx Consolidates Operating Companies ↗

April 05, 2023

FedEx (FDX) stock is on the move Wednesday after the company announced plans to consolidate some of its operating companies.

Via InvestorPlace

MorphoSys, Nuburu And Other Big Stocks Moving Higher On Wednesday ↗

April 05, 2023

U.S. stocks traded mixed, with the Dow Jones gaining more than 50 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

InflaRx: Q2 Earnings Insights ↗

August 05, 2022

InflaRx (NASDAQ:IFRX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings InflaRx reported EPS of $0.01.

Via Benzinga

InflaRx Shares Are Flying Higher After Emergency Use Nod Plans For Its COVID-19 Treatment ↗

July 26, 2022

Via Benzinga

Why Is InflaRx (IFRX) Stock Up 40% Today? ↗

July 26, 2022

Today's news that InflaRx plans to apply for FDA emergency-use authorization for its Covid-19 treatment has IFRX stock surging.

Via InvestorPlace

InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization ↗

April 05, 2023

InflaRx (IFRX) stock is getting a boost on Wednesday following an update from the FDA concerning its Covid-19 treatment.

Via InvestorPlace

Markets Mixed; US Trade Deficit Widens In February ↗

April 05, 2023

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13% to 33,446.10 while the NASDAQ...

Via Benzinga

Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

April 05, 2023

Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 05, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!

Via InvestorPlace

InflaRx Provides Development Update For Vilobelimab In Skin Disorder, COVID-19 ↗

June 29, 2022

Via Benzinga

InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients

April 04, 2023

From InflaRx N.V.

Via GlobeNewswire

This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗

August 01, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...

Via Benzinga

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗

July 27, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

Crude Oil Drops 1%; General Motors Earnings Miss Views ↗

July 26, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday.

Via Benzinga

Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session ↗

July 26, 2022

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

Via Benzinga

Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings ↗

July 26, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday.

Via Benzinga

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate ↗

July 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

InflaRx's Stock Gains Following FDA Fast Track Status To Skin Disease Drug ↗

July 06, 2022

The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).

Via Benzinga

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session ↗

June 29, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

LiveOne And 24 Stocks Moving Premarket ↗

June 29, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 92.9% to $0.2295 in pre-market trading. Allena Pharmaceuticals said it previously entered into at market issuance sales agreement with B. Riley...

Via Benzinga

InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗

June 29, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.